Navigation Links
'Twinkle' eye test could improve AMD diagnosis
Date:10/24/2007

Scientists at UCL (University College London) have developed a more reliable test for detecting vision loss in people with age-related macular disease (AMD), the leading cause of blindness in the UK and US. The method, which centres on a visual illusion, could lead to earlier self-diagnosis of sight deterioration encouraging patients to access medical assistance earlier on and potentially delay loss of vision.

Recent developments in the treatment of AMD mean that vision can be retained in some people with the injection of drugs into the eye, as long as they present to an eye clinic soon after the development of symptoms. These advances mean that accurate diagnosis is increasingly crucial in delaying sight-loss.

The new test, described in the current issue of PLoS ONE, relies on a visual illusion known as the twinkle after-effect, where a moving pattern can be induced in regions of the eye which have vision loss. Previously, this illusion has been demonstrated in normally sighted subjects, by using artificial scotoma (a way of blocking vision in a specific area). This is the first time it has been translated to people with eye disease and the results indicate it could be a powerful diagnostic tool.

Dr Michael Crossland, UCL Institute of Ophthalmology, is one of the researchers involved in this study. He explained: At present, people identified as being at risk of AMD are given a grid chart to observe on a daily basis, and are instructed to attend hospital if they notice any new distortion on this chart.

However, as many as 1 in 2 people will not be able to detect their vision loss using this chart, as the brain fills-in the missing information and perceives the chart as normal, when they actually should see distortion.

The initial data on our test indicates that it is quick, accurate and resistant to the effects of filling-in.

Dr Peter Bex from Harvard Medical School, a co-author on the paper, said: The qua
'/>"/>

Contact: Ruth Metcalfe
r.metcalfe@ucl.ac.uk
020-767-99739
University College London
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Virus Level could Predict Cervical Cancer Risk
2. Lean Protein Could Be Key to Obesity Drugs
3. Nasal Spray Could Take Drugs Direct to Brain.
4. Beware of the oral patch! It could be cancer!!!
5. Low Birth Weight infants could have Problems in the Future
6. False beliefs could cost cancer patients their lives
7. Oxygen Usage During Exercise Could Indicate Heart Problems
8. Prozac miracle could end in disaster
9. Wonder drug - could end in disaster
10. Pollution could be a risk
11. Fright could be more harmful
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2008)...eachMD, the first satellite radio,channel created...s, announced,today their newest strategic program...ors Association (AMDA), the professional associati...d others practicing in the long term care,continu...f AMDA says, "ReachMD provides a,great opportunit...
(Date:11/20/2008)...- Reno,s Downtown Ballroom was transformed into a ...over 850 guests filled the ballroom to help raise ...s, Saint Mary,s Regional Medical Center. Generatio...ent leaders, including Nevada Governor Jim Gibbons...edia News Release, go to: http://www.prnewswire.c...
(Date:11/20/2008)...re-USNewswire/ -- Yesterday, America,s Health Insu...ce industry had decided to support an "individual ...surance or pay a fine, combined with "guaranteed i...rdless of health status. , , But the Counc...as several health insurance company members, remai...
(Date:11/20/2008)...5,000 from Velocity hearing instrument sales. , ...ll/ -- Sonic Innovations, Inc. (Nasdaq: SNCI ) a...Forces Foundation (AFF) during a check presentatio...Paul Wennerholm and AFF President and Executive Di...donation is the result of a program conducted by S...
Breaking Medicine News(10 mins):Health News:ReachMD Announces New Strategic Partnership with American Medical Directors Association 2Health News:Photos: Nevada's Saint Mary's Regional Medical Center Raises $1.3 Million During Centennial Soiree 2Health News:CAHI Stands by Its Principles for Health Insurance Reform 2Health News:Sonic Innovations Presents Donation to the Armed Forces Foundation 2Health News:Sonic Innovations Presents Donation to the Armed Forces Foundation 3
...y been suggested to be a systemic disorder, not co...evidence indicates that AD is also associated with...tant markers in tests of given pathophysiological ...y of Medicine, University of Szeged, Hungary, hypo...
... always a source of family interest and general cu...s and also cause pregnancy related complications f...roblems as newborns and infants. But this is not ...re four times more likely to reach menopause early...
...zon for trigeminal neuralgia patients as researche...urgery (GKRS) is an effective way to deal with the...he Comprehensive Cancer Center at Wake Forest Univ... GKRS technique relived pain to a considerable deg...
...outcome of botulinum-a toxin (BTX-A) detrusor inje...c detrusor overactivity. BTX-A detrusor injections...ogenic detrusor overactivity due to spinal cord in...ble to carry out the same experiments successfully...
Other Medicine News:Health News:Age-Dependent Alterations Not Specific For Alzheimers Disease 2Health News:A New Approach In Treatment Neurogenic Detrusor Overactivity In Children 2
(Date:11/19/2008)...critical enzyme,s regulation may hold key to under... , , MEMPHIS, Tenn., Nov. 19 /PRNewswire-US...search Hospital have gained new insights into regu...ed calpains. , , As the cell,s molecular o...rocesses, including the movement of cells in tissu...
(Date:11/19/2008)... a contract development and,manufacturing organiz...st,phase launch of its contract facility in Delaw...he process, facility and capacity problems commonl...ow-volume clinical and,early-stage commercial ste...n invest over $100 million and four years to devel...
(Date:11/18/2008)... NeuroDiscovery Ltd (ASX:,NDL), a specialty neuro...any,and Sosei Group Corporation ("Sosei"; TSE Mo...armaceutical company, today announce that NeuroSol... efficacy data for NSL-043/SD118.,This investigat...pain and has,successfully completed Phase I clini...
(Date:11/18/2008)...on Medical Resources (AMR), a,provider of premier...agnostic,imaging industries, finds that over $10 ... U.S. during the third quarter of 2008. Privigen i... (IVIG) and was launched in the first,quarter of ...sma of thousands,of donors and is used to treat i...
Breaking Medicine Technology:New Insight Into the Controls on a Go-To Enzyme 2New Insight Into the Controls on a Go-To Enzyme 3Isogen Launches Major New Facility to Address Global Biopharma Demand 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Over $10 Million of CSL Behring's Privigen Was Sold in the U.S. During the Third Quarter of 2008 2First Lady Honors Women at International Womens Day Event 13817 1First Lady Honors Women at International Womens Day Event 13817 2Advanced Life Sciences Receives Nasdaq Notification 3796 1Advanced Life Sciences Receives Nasdaq Notification 3796 2Advanced Life Sciences Receives Nasdaq Notification 3796 3Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 13812 1Longs Drug Stores Announces Todd Vasos Executive Vice President and Chief Operating Officer 13812 2Researchers Design Promising Cancer Drug 13810 1Researchers Design Promising Cancer Drug 13810 2
...indings Reported Safety & Tolerability Profile...ects --, CHICAGO, June 25, 2007 /PRNewswire-FirstC...annual meeting of the American Diabetes,Associatio...ipeptidyl-peptidase-4 (DPP-4) in development by Br...mbination with metformin,exhibited a statisticall...
... and SUNNYVALE, Calif., June 27, 2007,/PRNewswire-...preliminary results from two open-label, multi-cen...al use of Xcytrin(R),(motexafin gadolinium) Inject...ination with Alimta(R) (pemetrexed) and in,combina... treatment,for patients with non-small cell lung c...
Other Medicine Technology:Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 2Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 3Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 4Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 5Data Demonstrated Saxagliptin Added to Metformin Improved Glycemic,Control in Subjects with Type 2 Diabetes Compared to Metformin,Alone 6Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 2Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 3Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 4Pharmacyclics Announces Interim Results From Two Ongoing Phase 2,Trials Supporting Potential of Xcytrin Plus Chemotherapy to Treat,Recurrent Non-Small Cell Lung Cancer 5
Since 1991 Intersurgical Incorporated manufactures high efficiency breathing filters, heat and moisture exchangers, ventilator circuits, oxygen therapy products, hand-held nebulizers and an extensive
...-Mist™ HME product line has the right produc...s and from intubated patients to patients with tra...cation for both anesthesia and critical care appli...ide maximum protection for patients and staff memb...
...-Mist™ HME product line has the right produc...s and from intubated patients to patients with tra...cation for both anesthesia and critical care appli...ide maximum protection for patients and staff memb...
Passive heat and moisture exchangers for respiratory applications.
Medicine Products: